September 02, 2014 7:54 PM ET

Biotechnology

Company Overview of Allozyne, Inc.

Company Overview

Allozyne, Inc., a biopharmaceutical company, provides novel protein therapeutic product candidates for the treatment of autoimmune and inflammatory diseases, and cancer. Its lead product candidate includes AZ01, a Phase 1b clinical trial product for the treatment of relapsing-remitting multiple sclerosis (RRMS). The company is also developing AZ17, a bispecific antibody for the treatment of various autoimmune and inflammatory diseases, including Crohn's disease and RRMS; and AZ05, an antibody-drug conjugate for the treatment of solid tumors. Allozyne, Inc. was founded in 2004 and is headquartered in Seattle, Washington. Allozyne, Inc. operates as a subsidiary of Poniard Pharmaceuticals, Inc.

1600 Fairview Avenue East

Suite 300

Seattle, WA 98102

United States

Founded in 2004

Phone:

206-518-5700

Fax:

206-518-5799

Key Executives for Allozyne, Inc.

Executive Chairman
Age: 67
Co-Founder and Member of the Scientific Advisory Board
Co-Founder and Member of Scientific Advisory Board
Vice President of Product Development
Chief Scientific Officer
Age: 63
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
AzurTec, Inc. United States
MoleculA Inc United States
GeneTrol Biotherapeutics, Inc. United States
Innovative BioTherapies, Inc. United States
ImmuneWorks, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Allozyne, Inc., please visit www.allozyne.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.